Pipeline

Pipeline Initial Indication(s) Discovery In vitroIn vivo (POC)IND-enabling Phase 1/2
xCT mAb (ADC) Breast, Colorectal, Liver, Lung
xCT-mAb radiopharmaceutical Breast, Colorectal, Liver, Lung
AX09 VLP-based vaccine Breast, Colorectal, Liver, Lung